THE TASK FORCE FOR GLOBAL HEALTH INC: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization: THE TASK FORCE FOR GLOBAL HEALTH INC (EIN 58-1698648)
Tax period: 2019-09-01 to 2020-08-31
Filed: 2021-04-19
IRS object ID: 202101169349300545
Schema version: 2019v5.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule G
Schedule J
Schedule K
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2021-04-19T09:42:14-07:00	ReturnTs
Tax Period End	2020-08-31	TaxPeriodEndDt
Return Type	990	ReturnTypeCd
Tax Period Begin	2019-09-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	581698648	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	THE TASK FORCE FOR GLOBAL HEALTH INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	TASK	BusinessNameControlTxt
Phone	4045921430	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	325 Swanton Way	AddressLine1Txt
City	Decatur	CityNm
State Abbreviation	GA	StateAbbreviationCd
ZIP	300303001	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	William Nichols	PersonNm
Person Title	Chief Operating Officer	PersonTitleTxt
Phone	4045921430	PhoneNum
Signature	2021-01-31	SignatureDt

Field	Value	IRS element (for citing)
Tax	2019	TaxYr
Build TS	2022-09-23 18:48:47Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	William P Nichols	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	325 Swanton Way	AddressLine1Txt
City	Decatur	CityNm
State Abbreviation	GA	StateAbbreviationCd
ZIP	30030	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$60,132,327	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	www.taskforce.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1986	FormationYr
Legal Domicile State	GA	LegalDomicileStateCd
Activity Or Mission	The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery.	ActivityOrMissionDesc
Voting Members Governing Body	11	VotingMembersGoverningBodyCnt
Voting Members Independent	10	VotingMembersIndependentCnt
Total Employee	172	TotalEmployeeCnt
Total Volunteers	5	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$54,141,049	PYContributionsGrantsAmt
CY Contributions Grants	$58,766,564	CYContributionsGrantsAmt
PY Program Service Revenue	$0	PYProgramServiceRevenueAmt
CY Program Service Revenue	$0	CYProgramServiceRevenueAmt
PY Investment Income	$845,317	PYInvestmentIncomeAmt
CY Investment Income	$639,010	CYInvestmentIncomeAmt
PY Other Revenue	-$54,150	PYOtherRevenueAmt
CY Other Revenue	-$512,427	CYOtherRevenueAmt
PY Total Revenue	$54,932,216	PYTotalRevenueAmt
CY Total Revenue	$58,893,147	CYTotalRevenueAmt
PY Grants And Similar Paid	$2,625,131	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$7,372,160	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$19,120,319	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$20,560,913	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$142,580	CYTotalFundraisingExpenseAmt
PY Other Expenses	$30,111,646	PYOtherExpensesAmt
CY Other Expenses	$31,889,462	CYOtherExpensesAmt
PY Total Expenses	$51,857,096	PYTotalExpensesAmt
CY Total Expenses	$59,822,535	CYTotalExpensesAmt
PY Revenues Less Expenses	$3,075,120	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$929,388	CYRevenuesLessExpensesAmt
Total Assets BOY	$66,280,703	TotalAssetsBOYAmt
Total Assets EOY	$67,961,569	TotalAssetsEOYAmt
Total Liabilities BOY	$12,754,635	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$15,364,889	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$53,526,068	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$52,596,680	NetAssetsOrFundBalancesEOYAmt
Mission	The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$21,504,134	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$26,694,191	RevenueAmt
Desc	The Training Program in Epidemiology and Public Health Interventions Network(TEPHINET): Key highlights from our work this year is to develop, connect, and mobilize a global field epidemiology workforce to strengthen public health systems and advance health security: 1) The TEPHINET Secretariat is developing a new strategic plan to drive our work over the next 5 years. 2) Launched a 10-year network-wide learning strategy to ensure a well-trained and professional global field epidemiology workforce prepared to address evolving public health priorities. 3) TEPHINET, CDC, and WHO identified public health leaders to invite as members of the FETP Enterprise Strategic Leadership Group (SLG) to implement the recommendations of the Global Field Epidemiology Roadmap. 4) Entered a new 5-year cooperative agreement with the CDC to execute more than 40 projects aimed at strengthening FETPs, trainees, alumni, and regional FETP networks, as well as improving detection and response to specific public health problems including non-communicable diseases, hepatitis, and COVID-19. 5) Sixteen FETPs received Emergency Capacity Building Grants from TEPHINET to support activities to strengthen their COVID-19 response and build capacity for response to future pandemics. 6) Through funded projects, TEPHINET provided operational support for COVID-19 response activities in 9 countries. 7) Hosted monthly global teleconferences for FETPs to share experiences, challenges, and lessons learned during COVID-19 response. 8) Accreditation Working Group developed standards for the accreditation of intermediate-level FETPs as well as a reaccreditation process for accredited FETPs. 9) Provided learning and professional development resources to FETP trainees and alumni, including a new e-learning course on scientific writing, a contact tracing course, and a webinar on becoming a public health emergency responder with GOARN. 10) Convened an expert working group to begin exploring strategies for TEPHINET to support scientific publishing among the field epidemiology community. 11) Together with partners around the world, celebrated the 40th anniversary of FETP. 12) Announced the first World Field Epidemiology Day to be held on September 7, 2021, to raise awareness of the important work of field epidemiologists and advocate for increased investment in building field epidemiology capacity globally. The Public Informatics Institute Program(PHII) provided direct services to the U.S. public health system through a cooperative agreement with the Centers for Disease Control (CDC) and funding from the Robert Wood Johnson foundation. This funding supported PHII and its partners in efforts to increase the capacity of public health informaticians and other public health leaders and practitioners to improve the collection, management and use of information and information technology for protecting and improving health and reducing disparities. Key activities included providing technical assistance and online tools to state and local health departments in linking to private healthcare electronic records systems for the purpose of electronically reporting disease cases; providing training to public health professionals in essential informatics competencies; convening and managing a forum to inform ongoing nationwide digital contact tracing efforts on COVID-19; and equipping pilot sites across the United States to commence data collection on opioid use disorder in pregnant women. Additionally, PHII is an ongoing partner on a collaborative Gates Foundation-funded project that is collecting data to reduce childhood mortality across the globe; this project is working on mortality surveillance activities at sites in Asia and Sub Saharan Africa. PHII is also engaged with USAID funding to conduct a vendor analysis and software evaluation on the creation and launch of a new, modernized database for tracking neglected tropical diseases. The existence of this database will unify and standardize tracking and data analysis efforts that are part of the global, inter-organizational campaign to eliminate and eradicate neglected tropical diseases. Health Campaign Effectiveness Program: During the 2020 fiscal year, the Program fostered cross-campaign learning and systems change in response to COVID-19's impact on planning, implementation, and follow-up. The advisory body convened by the Program to design the Health Campaign Effectiveness Coalition assumed the COVID-19 pandemic will continue to dramatically alter how campaigns function in the future and present new opportunities and challenges for collaboration across campaigns. Thirteen organizations with global reach contributed to and agreed on the Health Campaign Effectiveness Coalition design, vision, goal, and theory of change. The Program is building the evidence base on campaign effectiveness and responding to the impact of COVID-19 on campaigns. The Program engaged more than 30 peer reviewers in the development of technical briefs and collection of more than 280 guidance documents, articles, and best practices in cross-cutting topics across health campaign domains. List of countries the Program has engaged with during FY20: Ethiopia, Ghana, Guyana, India, Kenya, Nepal, Nigeria, Pakistan, Somalia and S. Sudan The MedSurplus Alliance Program(MSA): is a cross-sector alliance that works collaboratively to improve access to quality donated medical products through accreditation, donation initiatives, capacity-building, technology solutions, and leadership. MSA Accredited Medical Surplus Recovery Organizations (MSROs) and Ascension Health MSA are providing essential medical supplies, devices, and equipment to clinical settings worldwide and low resourced communities in the United States. Annually, MSROs ship over 700 40ft containers of supplies and equip thousands of small medical mission trips. Dispensary of Hope accepted a significant donation of the difficult to obtain drug hydroxychloroquine for distribution in the United States to treat patients with rheumatoid arthritis, lupus symptoms, childhood arthritis (or juvenile idiopathic arthritis), and other autoimmune diseases. Supplies OverSeas donated over $1,000,000 in PPE and equipment to hospitals, clinics, first responders, free testing sites, and 70 nursing homes. The kits4Life Program includes four medication study sponsors (Eli Lilly, Bayer, Janssen, Sanofi US) and five Medical Surplus Recovery Organizations. Together they collected and donated products from clinical research sites in 25 states. Kits4Life enabled the donation of at least 5,810 medical devices, pieces of equipment, and cases of products to health systems in The Bahamas, Belize, Ghana, Grenada, Guatemala, Eswatini, Haiti, Kenya, and the United States of America. COVID-19 Response: Medical product donations make it possible for doctors, nurses, and healthcare workers to combat disease outbreaks, epidemics, and pandemics by providing the supplies and equipment they need. When COVID-19 emerged in Asia, MSROs were well prepared to provide over 9 million masks, gowns, and gloves to combat the initial epidemic. Today as the virus spreads at home, the MSA and its members have turned their attention to meeting local needs. The MSA and its members provide donations, support supply chain collaborations, and provide warehouse services to donors, hospitals, and health systems changing conditions	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$18,604,197	ExpenseAmt
Grant	$6,808,340	GrantAmt
Revenue	$19,890,102	RevenueAmt
Desc	The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma, even in the midst of a global pandemic. ITI contributes to the ultimate elimination of trachoma by stewarding Pfizer's donation of Zithromax(R) to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. One of the many highlights of 2020 involved ITI delivering the country of Nauru its first-ever Zithromax(R) shipment; from Brussels to Singapore to Brisbane to Nauru, the shipment included 14,448 treatments with a total distance of 12,451 miles. Nauru conducted its first trachoma mass drug administration (MDA) in May 2020 and wrapped up MDAs in June 2020. Between September 2019 to August 2020, ITI also organized just-in-time shipments of 29,754,936 million treatments for trachoma shipped to be distributed at MDAs in 15 countries. In the first nine months of 2020, more than 9 million people no longer needed Zithromax(R) for trachoma treatment (as of August 25, 2020). As of August 2020, ITI has shipped more than 905 million treatments to trachoma endemic countries since 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision making on where antibiotic treatments are needed and where they can be stopped. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.2 billion people in 2000 to 136.9 million in May 2020 according to the World Health Organization's (WHO) Weekly Epidemiological Record (WER). ITI will continue to work smarter so that the dream of a trachoma free world becomes a reality. The Mectizan Donation Program: In 2020, MDP approved 433 million treatments including 371.5 million treatments in countries where LF and onchocerciasis are co-endemic and 61.5 million treatments in IDA countries and actively contributed in the promotion of the new WHO NTD road map and participated in many virtual meetings. At country level, because of the pandemic, the 2020 MDAs were cancelled in part of or in all endemic districts in many African countries like Nigeria which received 48% of the 749.8 million tablets shipped in 2020. Part of the 2020 budget surplus was reallocated in a special grant announced by Merck to support countries through the partner NGO in their effort to prevent SARS-Cov2 contamination when resuming MDA in countries. As of December 31, 2020, 7 grants ($210,863) were disbursed including 2 to The Carter Center for Ethiopia and Nigeria, 2 to Christian Blind Mission for CAR and South Sudan, 3 to Helen Keller International for Cameroon, Niger, and Nigeria). The remaining $289,137 are carried over to be issued in 2021. Global Partnership for Zero Leprosy Program(GPZL): In September of 2019 GPZL launched the Zero Leprosy Toolkit at the 20th International Leprosy Congress in Manila, making available to the leprosy community a large body of best practices intended to improve and inform their work. In November GPZL conducted a Single-Dose Rifampicin Post-Exposure Prophylaxis (SDR-PEP) Research and Practice Workshop in partnership with the Leprosy Research Institute and Netherlands Leprosy Relief in Amsterdam. Additionally, in November, GPZL jointly conducted a country review of the Moroccan National Leprosy Program with WHO's Global Leprosy Program and helped the program craft a roadmap to zero leprosy for the country. In January of 2020, GPZL began the process of selecting 10 new country partners. Following examination of 23 applications based on indicators for readiness, in-country partner networks, program needs, and political criteria, GPZL selected the following countries to implement the Zero Leprosy Country Model: Cambodia, Cote d'Ivoire, Federated States of Micronesia, Ghana, Kiribati, Marshall Islands, Mozambique, Nigeria, Tanzania, and Uganda. In March and April, the Global Partnership shifted attention to COVID-19 related challenges facing the leprosy community. GPZL launched three COVID-19 emergency response working groups. The first working group, the Leprosy Emergency Operations Committee, resolved multi-drug therapy (MDT) distribution issues to ensure that leprosy patients could access the medication they need. The second working group, the Emergency Advocacy for Persons Affected Working Group, consulted with more than 125 persons affected by leprosy from 20 plus countries to gather information about the leprosy community's needs during the pandemic and advise NGOs and governments on how to meet these needs. GPZL published the results of this global consultation in a publication in Leprosy Review, via an information dashboard on the GPZL website, and a fact sheet. This working group also partnered with a group of women affected to produce a video about the findings of the consultative calls. The third working group, the Post COVID-19 Working Group, met to discuss a path forward for the leprosy community in a post-COVID world through conversations with stakeholders, increased collaboration, and stronger alignment of the leprosy community in preparation for future challenges. In addition to the working groups, GPZL issued guidance about leprosy and COVID-19, in partnership with WHO's Global Leprosy Program and ILEP, in response to the pandemic. This guidance, along with partner resources, news related to COVID-19, and products from the three working groups, comprised the COVID-19 Resource Hub, created on the GPZL website in May and June. Also in June, GPZL, in partnership with WHO GLP, conducted a webinar on single-dose rifampicin post-exposure prophylaxis (SDR-PEP), exploring the process of starting SDR-PEP implementation for National Leprosy Programs. In July GPZL began a mathematical modeling project that created models demonstrating the impact of leprosy investment on the burden of disease, encouraging increased investment from international donors and national governments. Neglected Tropical Diseases Support Center(NTD-SC): Funded principally by the Bill & Melinda Gates Foundation, the U.S. Agency for International Development and the United Kingdom AID (UK AID), the NTD-SC aims to optimize Operational Research (OR) to eliminate neglected tropical diseases which threaten the lives and well-being of more than one billion of people in some of the world's poorest communities. As of 2020, the NTD-SC manages a portfolio of more than 250 OR projects spanning 60 countries, and targeting all five neglected tropical diseases amenable to preventive chemotherapy: lymphatic filariasis, onchocerciasis, STH, schistosomiasis and trachoma, morbidity and social science. Some of these OR study products have resulted into program recommendations which the World Health Organization (WHO) has endorsed and adopted into WHO policy while others are clinical trials which may result in new therapies for NTD diseases. Moreover, The African Research Network for Neglected Tropical Diseases (ARNTD) is another funding program facilitated through NTD-SC with funding from USAID and UK Aid. In addition, the NTD-SC serves as the Secretariat for the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) yearly meeting. This meeting brings together a growing group of researchers and country program implementers working to foster important collaborations to address the challenges faced by NTD programs which prevent the shared goal of eliminating these infections. The 2-day event convened 450 individuals from more than 40 countries and 128 organizations with 80 proposals for 24 breakouts sessions and 13 innovations, translating ideas into future OR projects for 2020. In addition, the NTD-SC is working with African Research Network for NTDs (ARNTD) support the third cycle of small grants program (SGP) to develop research capacity in the African region and sponsored by USAID and UKAID. This continues to be competitive among African researchers, resulting in high-quality projects supported through the grants.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$10,380,451	ExpenseAmt
Grant	$563,820	GrantAmt
Revenue	$11,883,923	RevenueAmt
Desc	POLIO PROGRAM: Since early April 2019, the Polio Outbreak Response Technical Support Team deployed a total of 14 times to Ghana, Ethiopia, Indonesia, Congo-Brazzaville, and Zambia. In a time of growing scale and scope of circulating type 2 vaccine-derived poliovirus (cVDPV2) outbreaks, the Outbreak Response Team provides highly respected and valued expertise across the Global Polio Eradication Initiative (GPEI) partnership to ministries of health to improve active case search, enhance surveillance efforts, and support for planning and implementation of vaccination campaigns. Supplementary immunization activities targeted hundreds of millions of children since the team was created, and the long-term nature of their deployments has provided essential continuity in settings that often see high turnover of staff. In Ethiopia and Zambia, members of the team have taken the lead on supporting the Ministries of Health in developing comprehensive surveillance proposals for continued use, with SOPs and protocol for district surveillance staff. These include the utilization of Field Epidemiology Training Program (FETP) residents as sources of valuable local human resource capacity. The institutionalization of this expertise is crucial for these countries working towards controlling outbreaks and ultimately eradicating polio. Polio Antivirals Initiative: The objective of the Polio Antivirals Initiative is to develop two antiviral agents with different mechanisms of action that can be used to safely and effectively treat B cell deficient wild or vaccine-derived prolonged poliovirus excerpters. These individual are at risk of developing paralytic disease and/or dying and transmitting the virus to others. Two virus-specific antiviral agents, pocapavir and V-7404, are presently undergoing preclinical and clinical evaluation by ViroDefense Inc. This year, a Phase 1 single and multiple dose clinical study was completed with V-7404. V-7404 was generally well tolerated and oral administration resulted in plasma concentrations that are expected to be effective in inhibiting poliovirus replication when administered in combination with pocapavir. The GMP manufacturing of bulk drug substance and product have been conducted and placed on stability. Work is underway to submit the regulatory work to enable the conduct of a Phase 1 clinical study of the combination of pocapavir and V-7404. Discussions with WHO have been held to discuss the potential Emergency Use Listing of the combination following completion of the necessary clinical studies. The Partnership for Influenza Vaccine Introduction (PIVI) is a public/private program that works in partnership with the Centers for Disease Control and Prevention (CDC), Ministries of Health, corporate partners and others to create sustainable, seasonal influenza vaccination programs in low- and middle-income countries. PIVI donated 18,500 influenza vaccines during the FY (to Macedonia and Cote d'Ivoire), and awarded 10 sub-awards including: Albania (communications, capacity building for flu fighters); Bhutan (multi-year award - communications materials, capacity building for health workers); Cote d'Ivoire (operational costs for vaccinating health workers); Kenya (assess introduction of flu program on EPI rates); Laos (multi-year award - estimate cost of flu illness outpatient/inpatient, conduct iPIE to estimate cost of flu program); Kyrgyzstan (multi-year - NITAG training, economic burden study); Mongolia (KAP, communications materials); North Macedonia (communications materials, health worker training, improve cold chain, increase accessibility of flu vaccine); SECID (multi-year - analysis of joint procurement, training on flu vaccination), Vietnam (multi-year - 3 regional workshops and AEFI surveillance). Ready2Respond (R2R) operates as a global collaboration of partners from the public, private and non-profit sectors committed to augmenting low- and middle-income countries' readiness to respond against influenza and emerging respiratory viral pandemics. The Global Funders Consortium for Universal Influenza Vaccine Development is a mechanism to bring together major funders of research and development of universal influenza vaccines along with key stakeholders to accelerate progress in the field through creating a common landscape, identifying critical gaps, and coordinating around a common vision. During FY20 the Consortium convened its third annual in-person meeting (November 2019) to review work done and plan for the coming year. During this meeting, the Consortium conducted its first industry engagement meeting which was attended by 14 manufacturers and several funders and provided an open discussion on universal influenza development from the industry perspective. Progress over the past FY included: creating a mechanism for sharing data and activities - including meeting, calls, web-site, peer-reviewed papers, industry engagement, annual meetings and reports; initiating work on tools for stakeholders including - Influenza Vaccine Roadmap; Technology Landscape; Protocol Sharing Platform; a meeting on Modelling for Investment Case for Universal Influenza Vaccine; and facilitating co-funding opportunities including - Bill & Melinda Gates Foundation and Flu Lab Grand Challenges; European Union / Indian Collaboration; Innovation working Group; Sabin-Aspen Vaccine & Policy Group; and the Industry Engagement Work Group. Brighton Collaboration Program: The Coalition for Epidemic Preparedness Innovations (CEPI) funded Brighton Collaboration and its Safety Platform for Emergency vACcines (SPEAC), both established at the TFGH in 2019, experienced exponential growth with the advent of the COVID-19 pandemic at the start of 2020. From a programmatic perspective, the SPEAC team planned to meet its objectives to enhance vaccine safety assessment across CEPI development programs, harmonize safety assessments during clinical trials and continuously improve the SPEAC program framework. Through early January 2020, SPEAC prepared for scale up and an extension of its original scope of work: to grow the CEPI portfolio beyond its initial focus on Lassa Fever to include landscape analyses of other target diseases such as MERS, Nipah, Rift Valley Fever and Chikungunya, to continue to support new vaccine developers, to reinforce its structure and procedures to implement the scope of work and upscale its support structure through the identification, recruitment and training of additional clinical safety experts worldwide, with a special focus on Low-to-Middle-Income Countries (LMICs). The very next month (Feb 2020), stakeholders recognized that a significant amount of effort would need to be diverted to learning about and responding to the evolving nature of the novel Coronavirus (COVID-19). As the challenges grew, SPEAC adapted quickly and increase its capacity, more rapidly than anticipated, to support developers and CEPI. Since then, it has focused mostly on the COVID-19 pandemic, notably successfully: 1) organized a global consensus webinar on and publication of vaccine-associated enhanced disease (VAED), 2) developed a draft list of COVID-19 Adverse Events of Special Interest (AESI) and updated it quarterly based on the rapidly exploding medical literature, 3) developed standardized Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO), in other words safety templates, for each of the major COVID-19 vaccine technology platforms: nucleic acid, protein, viral vector, inactivated and live viral vaccines, 4) presented both the AESI list and BRAVATO safety templates to the World Health Organization (WHO) Global Advisory Committee on Vaccine Safety (GACVS) in May 2020 for its endorsement, 5) developed and published standardized case definition for Sensori-neural hearing loss and formed a working group for VAED, 6) created a functional meta-Data Safety Monitoring Board (DSMB), 7) formed ad hoc review boards for urgent safety issues that arose during clinical trials. Hepatitis Program: The COVID-19 pandemic disrupted all aspects of society, including efforts to combat viral hepatitis. Nonetheless, the Coalition remained committed to supporting the work of hepatitis elimination programs either by providing resources to inform the continuation of hepatitis services under changing conditions or by spearheading initiatives to keep hepatitis elimination on national and global health agenda. Below is a summary of the Coalition's achievements in 2020: 1) The Coalition presented at the 2019 European CDC (ECDC) Network Meeting in September 2019. 2) The Coalition participated in the 2019 WHO Eastern Mediterranean Region Hepatitis Advisory Board meeting in Lahore, Pakistan. 3) The Coalition led organization of the International Viral Hepatitis Elimination meeting in December 2019. 4) The Coalition launched the "Innovations in Hepatitis Elimination" to highlight real-world efforts advancing hepatitis B and C elimination globally in February2020	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$0	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$0	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$0	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$50,488,782	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	0	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Donor Rstr Or Quasi Endowments	0	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	0	ProfessionalFundraisingInd
Fundraising Activities	Yes (1)	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	0	GrantsToOrganizationsInd
Grants To Individuals	0	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (1)	TaxExemptBondsInd
Invest Tax Exempt Bonds	0	InvestTaxExemptBondsInd
Escrow Account	0	EscrowAccountInd
On Behalf Of Issuer	0	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	0	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	0	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	132	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Employee	172	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	Yes (1)	ForeignFinancialAccountInd
Foreign Country	CO	ForeignCountryCd
Foreign Country	ET	ForeignCountryCd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	0	QuidProQuoContributionsInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	0	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	11	GoverningBodyVotingMembersCnt
Independent Voting Member	10	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	Daniel N Martins	PersonNm
Phone	4046875620	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	325 Swanton Way	AddressLine1Txt
City	Decatur	CityNm
State Abbreviation	GA	StateAbbreviationCd
ZIP	300303001	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (24 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
David A Ross
President and CEO	39	1	Yes (X)	Yes (X)	$372,633	$0	$53,116
Mark McKinlay
Program Director	39	0		Yes (X)	$259,698	$0	$53,454
Patrick O'Carroll
Program Sector Head	39	1			$272,456	$0	$26,104	Yes (X)
David G Addis
Program Director	40	0			$241,288	$0	$51,074		Yes (X)
Rubina Imitaz
Program Director	40	0			$237,380	$0	$53,104		Yes (X)
Paul Emerson
Program Director	40	0			$232,408	$0	$53,104	Yes (X)
William P Nichols
Chief Operating Officer	39	0		Yes (X)	$259,555	$0	$24,517
Yao Sodahlon
Program Director	40	0			$221,855	$0	$61,487		Yes (X)
Martha Rogers
Program Director	40	0			$257,008	$0	$23,768		Yes (X)
Vivian Singletary
Program Director	40	0			$213,388	$0	$49,038	Yes (X)
Patrick Lammie
Sr. Public Health Scientist	40	0			$218,731	$0	$20,664	Yes (X)
Heather Brooks
Director of Organizational Effectiveness	39	1		Yes (X)	$181,826	$0	$40,056
Daniel Martins
Chief Financial Officer	39	1		Yes (X)	$146,038	$0	$56,429
Ellen Wild
Director of Business Strategy	39	1		Yes (X)	$167,084	$0	$16,019
Teri Plummer McClure
Board Chair	1	0	Yes (X)		$0	$0	$0
Paula Lawton Bevington
Board Member	1	0	Yes (X)		$0	$0	$0
Charles H McTier
Board Member	1	0	Yes (X)		$0	$0	$0
Kent Alexander
Board Member	1	0	Yes (X)		$0	$0	$0
James Jackson
Board Member	1	0	Yes (X)		$0	$0	$0
Deborah Kilpatrick
Board Member	1	0	Yes (X)		$0	$0	$0
Walter Orenstein
Board Member	1	0	Yes (X)		$0	$0	$0
James W Curran
Board Member	1	0			$0	$0	$0			Yes (X)
Mary Ann Peters
Board Member	1	0			$0	$0	$0			Yes (X)
Wonya Lucas
Board Member	1	0			$0	$0	$0			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$3,281,348	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$581,934	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	47	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (1)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	Address Line2ContractorAddress/USAddress/AddressLine2Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
Freese Johnson Construction Company
1355 Terrell Mill Rd Bldg 1470	Suite 100	Marietta	GA	30067	Building Construction Company	$1,006,844
Deloitte Consulting LLP
4022 Sells Drive		Hermitage	TN	37076	Consulting services	$346,000
Golin Harries International Inc
777 Brickell Avenue Suite 1390		Miami	FL	33131	Consulting services	$263,583
Robert Chen
2131 Briarlake Trace NE		Atlanta	GA	30345	Vaccine consulting services	$179,523
HLN Consulting
9 Pemberly		Mission Viejo	CA	92692	Informatic services	$160,345

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	1	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$0	FederatedCampaignsAmt
Membership Dues	$0	MembershipDuesAmt
Fundraising	$0	FundraisingAmt
Related Organizations	$0	RelatedOrganizationsAmt
Government Grants	$29,210,709	GovernmentGrantsAmt
All Other Contributions	$29,555,855	AllOtherContributionsAmt
Noncash Contributions	$0	NoncashContributionsAmt
Total Contributions	$58,766,564	TotalContributionsAmt
Total Program Service Revenue	$0	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$639,010	TotalRevenueColumnAmt
Related Or Exempt Func Income	$639,010	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$638,835	RealAmt
Personal	$0	PersonalAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$1,096,600	RealAmt
Personal	$0	PersonalAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	-$457,765	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$457,765	TotalRevenueColumnAmt
Related Or Exempt Func Income	-$457,765	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$0	SecuritiesAmt
Other	$0	OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$0	SecuritiesAmt
Other	$0	OtherAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$0	SecuritiesAmt
Other	$0	OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$87,918	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$0	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$142,580	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$54,662	TotalRevenueColumnAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	-$54,662	ExclusionAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$0	GamingGrossIncomeAmt
Gaming Direct Expenses	$0	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$0	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$58,893,147	TotalRevenueColumnAmt
Related Or Exempt Func Income	$181,245	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	-$54,662	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$7,372,160	TotalAmt
Program Services	$7,372,160	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$2,722,298	TotalAmt
Program Services	$1,261,752	ProgramServicesAmt
Management And General	$1,460,546	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$13,850,946	TotalAmt
Program Services	$10,757,838	ProgramServicesAmt
Management And General	$2,999,763	ManagementAndGeneralAmt
Fundraising	$93,345	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,036,005	TotalAmt
Program Services	$804,651	ProgramServicesAmt
Management And General	$224,372	ManagementAndGeneralAmt
Fundraising	$6,982	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$1,972,432	TotalAmt
Program Services	$1,452,213	ProgramServicesAmt
Management And General	$507,350	ManagementAndGeneralAmt
Fundraising	$12,869	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$979,232	TotalAmt
Program Services	$749,076	ProgramServicesAmt
Management And General	$223,655	ManagementAndGeneralAmt
Fundraising	$6,501	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$13,545,800	TotalAmt
Program Services	$13,127,078	ProgramServicesAmt
Management And General	$396,094	ManagementAndGeneralAmt
Fundraising	$22,628	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$37,069	TotalAmt
Program Services	$10,918	ProgramServicesAmt
Management And General	$26,151	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$47,552	TotalAmt
Program Services	$9,661	ProgramServicesAmt
Management And General	$37,891	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Fundraising	$0	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$52,021	TotalAmt
Program Services	$17,425	ProgramServicesAmt
Management And General	$34,596	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$796,946	TotalAmt
Program Services	$555,399	ProgramServicesAmt
Management And General	$241,439	ManagementAndGeneralAmt
Fundraising	$108	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$719,328	TotalAmt
Program Services	$437,993	ProgramServicesAmt
Management And General	$281,335	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$364,613	TotalAmt
Program Services	$50,572	ProgramServicesAmt
Management And General	$314,041	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$4,308,108	TotalAmt
Program Services	$4,164,224	ProgramServicesAmt
Management And General	$143,859	ManagementAndGeneralAmt
Fundraising	$25	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$2,880,101	TotalAmt
Program Services	$2,755,203	ProgramServicesAmt
Management And General	$124,898	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$383,501	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$383,501	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$1,434,026	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$1,434,026	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$166,288	TotalAmt
Program Services	$34,118	ProgramServicesAmt
Management And General	$132,170	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
Bank Charges	$84,904	$78,898	$5,884	$122
Dues and Subscriptions	$109,622	$66,203	$43,419	$0
Miscellaneous	$141,812	$51,615	$90,197	$0
Other Direct Program Expense	$6,817,771	$6,731,785	$85,986	$0

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$59,822,535	TotalAmt
Program Services	$50,488,782	ProgramServicesAmt
Management And General	$9,191,173	ManagementAndGeneralAmt
Fundraising	$142,580	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$23,052,659	BOYAmt
EOY	$26,666,556	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$6,616,340	BOYAmt
EOY	$3,766,415	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$627,134	BOYAmt
EOY	$2,357,836	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$31,643,040	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$6,739,838	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$26,303,999	BOYAmt
EOY	$24,903,202	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$9,680,571	BOYAmt
EOY	$10,267,560	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$66,280,703	BOYAmt
EOY	$67,961,569	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$3,073,697	BOYAmt
EOY	$3,806,089	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$1,982,212	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$6,125,000	BOYAmt
EOY	$5,775,000	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$3,555,938	BOYAmt
EOY	$3,801,588	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$12,754,635	BOYAmt
EOY	$15,364,889	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$25,124,158	BOYAmt
EOY	$27,164,362	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$28,401,910	BOYAmt
EOY	$25,432,318	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$53,526,068	BOYAmt
EOY	$52,596,680	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$66,280,703	BOYAmt
EOY	$67,961,569	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	-$929,388	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$0	NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts	$0	DonatedServicesAndUseFcltsAmt
Investment Expense	$0	InvestmentExpenseAmt
Prior Period Adjustments	$0	PriorPeriodAdjustmentsAmt
Other Changes In Net Assets	$0	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	Yes (1)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (1)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$42,374,053	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$68,115,208	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$36,813,330	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$47,166,232	CurrentTaxYearMinus1YearAmt
Current Tax Year	$45,641,975	CurrentTaxYearAmt
Total	$240,110,798	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$0	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$0	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$0	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$0	CurrentTaxYearMinus1YearAmt
Current Tax Year	$0	CurrentTaxYearAmt
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$0	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$0	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$0	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$0	CurrentTaxYearMinus1YearAmt
Current Tax Year	$0	CurrentTaxYearAmt
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$42,374,053	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$68,115,208	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$36,813,330	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$47,166,232	CurrentTaxYearMinus1YearAmt
Current Tax Year	$45,641,975	CurrentTaxYearAmt
Total	$240,110,798	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$46,092,512	SubstantialContributorsTotAmt
Public Support Total170	$194,018,286	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$8,370	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$89,763	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$825,669	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,189,041	CurrentTaxYearMinus1YearAmt
Current Tax Year	$1,412,850	CurrentTaxYearAmt
Total	$3,525,693	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$0	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$0	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	-$222,353	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	-$598,040	CurrentTaxYearMinus1YearAmt
Current Tax Year	-$457,765	CurrentTaxYearAmt
Total	-$1,278,158	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$0	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$0	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$0	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$0	CurrentTaxYearMinus1YearAmt
Current Tax Year	$0	CurrentTaxYearAmt
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$242,358,333	TotalSupportAmt
Gross Receipts Rltd Activities	$0	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.80054	PublicSupportCY170Pct
Public Support PY170	0.79260	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests PY170	Yes (X)	ThirtyThrPctSuprtTestsPY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule D IRS990ScheduleD

Land LandGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$2,135,100	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$0	OtherCostOrOtherBasisAmt
Book Value	$2,135,100	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$26,211,582	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$0	OtherCostOrOtherBasisAmt
Depreciation	$4,293,423	DepreciationAmt
Book Value	$21,918,159	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$0	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$0	OtherCostOrOtherBasisAmt
Depreciation	$0	DepreciationAmt
Book Value	$0	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$1,456,619	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$0	OtherCostOrOtherBasisAmt
Depreciation	$1,232,850	DepreciationAmt
Book Value	$223,769	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$1,839,739	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$0	OtherCostOrOtherBasisAmt
Depreciation	$1,213,565	DepreciationAmt
Book Value	$626,174	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$24,903,202	TotalBookValueLandBuildingsAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)

DescDesc	AmtAmt
Interest Rate Swap Liability	$496,860
Accrued Absences	$401,734
Payroll Liabilities	$1,767,631
Other Accrued Liabilities	$1,135,363

Field	Value	IRS element (for citing)
Total Liability	$3,801,588	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$58,841,125	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	$0	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$0	DonatedServicesAndUseFcltsAmt
Recoveries Prior Year Grants	$0	RecoveriesPriorYearGrantsAmt
Other Revenue	$0	OtherRevenueAmt
Revenue Not Reported	$0	RevenueNotReportedAmt
Revenue Subtotal	$58,841,125	RevenueSubtotalAmt
Investment Expenses Not Incld	$52,022	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	$0	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	$52,022	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$58,893,147	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$59,770,513	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$0	DonatedServicesUseFcltsAmt
Prior Year Adjustments	$0	PriorYearAdjustmentsAmt
Losses Reported	$0	LossesReportedAmt
Other Expenses Included	$0	OtherExpensesIncludedAmt
Expenses Not Reported	$0	ExpensesNotReportedAmt
Expenses Subtotal	$59,770,513	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$52,022	InvestmentExpensesNotIncld2Amt
Other Expenses Not Included	$0	OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt	$52,022	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$59,822,535	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule D, Part X, Line 2	FormAndLineReferenceDesc
Explanation	Not Applicable. The organization does not have any uncertain tax liability.	ExplanationTxt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (13 entries)

RegionRegionTxt	OfficesOfficesCnt	EmployeeEmployeeCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
Central America and the Caribbean	0	0	Program Services	Operational research to support the control and elimination of five neglected tropical diseases: lymphatic filariasis, onchocerciasis, trachoma, STH and schistosomiasis. This work is conducted in close collaboration with research partners around the world, and there is an effort made to ensure that the work itself is embedded in the ministries of health. The NTD Support Center manages small grants to these research partners to conduct the work, providing technical support and oversight on each research project and they synthesizing the findings and presenting the results to the World Health Organization.	$499,873
East Asia and the Pacific	0	0	Program Services	Operational research to support the control and elimination of five neglected tropical diseases: lymphatic filariasis, onchocerciasis, trachoma, STH and schistosomiasis. This work is conducted in close collaboration with research partners around the world, and there is an effort made to ensure that the work itself is embedded in the ministries of health. The NTD Support Center manages small grants to these research partners to conduct the work, providing technical support and oversight on each research project and they synthesizing the findings and presenting the results to the World Health Organization.	$101,203
South Asia	0	0	Program Services	Operational research to support the control and elimination of five neglected tropical diseases: lymphatic filariasis, onchocerciasis, trachoma, STH and schistosomiasis. This work is conducted in close collaboration with research partners around the world, and there is an effort made to ensure that the work itself is embedded in the ministries of health. The NTD Support Center manages small grants to these research partners to conduct the work, providing technical support and oversight on each research project and they synthesizing the findings and presenting the results to the World Health Organization.	$1,130,583
Sub-Saharan Africa	0	0	Program Services	Operational research to support the control and elimination of five neglected tropical diseases: lymphatic filariasis, onchocerciasis, trachoma, STH and schistosomiasis. This work is conducted in close collaboration with research partners around the world, and there is an effort made to ensure that the work itself is embedded in the ministries of health. The NTD Support Center manages small grants to these research partners to conduct the work, providing technical support and oversight on each research project and they synthesizing the findings and presenting the results to the World Health Organization.	$4,382,381
Middle East and North Africa	0	0	Program Services	Operational research to support the control and elimination of five neglected tropical diseases: lymphatic filariasis, onchocerciasis, trachoma, STH and schistosomiasis. This work is conducted in close collaboration with research partners around the world, and there is an effort made to ensure that the work itself is embedded in the ministries of health. The NTD Support Center manages small grants to these research partners to conduct the work, providing technical support and oversight on each research project and they synthesizing the findings and presenting the results to the World Health Organization.	$5,607
Sub-Saharan Africa	2	12	Program Services	World Health Organization for GET2020 global trachoma elimination planning conference. Grant to GTM Ethiopia for eliminattion of blinding Trachoma specifically for implementing SAFE strategy in the Oromia region of Ethiopia	$301,592
Sub-Saharan Africa	0	0	Program Services	Support for Oncho elimination efforts in Africa, Survey, Evaluation of Oncho Burden, Upscale of MDA, Logistical support and training and gap funding for Cameroon.	$301,318
Sub-Saharan Africa	0	0	Program Services	Grant to Kenya Red Cross & African Field Epidemiology to implement , train and evaluate the epidemiological support for soil transmission and elimination.	$85,783
East Asia and the Pacific	0	0	Program Services	Lao - Vaccine purchase and subaward agreement for Cost Effectiveness study and iPIE; Mongolia - the economic burden study, KAP study and developing and distributing communications materials	$253,350
South Asia	0	0	Program Services	Bhutan - Information materials and vaccine distribution, capacity building of health workers; Vietnam - communications materials, survey in four provinces on the flu campaign; regional workshops and active AEFI surveillance	$59,748
Sub-Saharan Africa	0	0	Program Services	Cote d'Ivoire - Vaccine and syringes purchase; operational cost for vaccinating health care workers against seasonal influenza across twelve health regions of Cote d'Ivoire; Kenya- Assessment of the impact of the introduction of seasonal influenza vaccination on routine EPI vaccine coverage rates and program implementation.	$144,069
Middle East and North Africa	0	0	Program Services	Morocco - Preparation for Influenza workshops and economic burden study	$44,860
Russia and the newly independent States	0	0	Program Services	Tajikistan - KAP Study; Kyrgyzstsan - NITAG strenthening and Economic Burden Study	$61,793

Field	Value	IRS element (for citing)
Total Office	2	TotalOfficeCnt
Total Employee	12	TotalEmployeeCnt
Total Spent	$7,372,160	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (6 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt
Central America and the Caribbean	necessary, is made.	$499,873	Wire tansfer	$0
East Asia and the Pacific	Program activities.	$354,553	Wire transfer	$0
South Asia	Program activities	$1,190,331	Wire transfer	$0
Sub-Saharan Africa	Program activities	$5,215,143	Wire transfer	$0
Middle East and North Africa	Program activities	$50,466	Wire transfer	$0
Russia and the newly independent States	Program services	$61,793	Wire transfer	$0

Field	Value	IRS element (for citing)
Total501c3 Org	33	Total501c3OrgCnt
Total Other Org	61	TotalOtherOrgCnt
Transfer To Foreign Corp	0	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule F, Part I, Line 2	FormAndLineReferenceDesc
Explanation	A contract is executed with all the required deliverables and budget. Based on work performance, an agreed percentage of the grant is paid to the recipient after receiving an invoice and a narrative report. Occasionally, there are visits to the countries for feedback and to assess the impact of the project. Budget over-runs have to be explained before a contract amendment, if necessary, is made.	ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	General fundraising	Event1Nm
Gross Receipts Event1	$87,918	GrossReceiptsEvent1Amt
Charitable Contri Event1	$0	CharitableContriEvent1Amt
Gross Revenue Event1	$87,918	GrossRevenueEvent1Amt
Cash Prizes Event1	$0	CashPrizesEvent1Amt
Non Cash Prizes Event1	$0	NonCashPrizesEvent1Amt
Rent Facility Costs Event1	$0	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$0	FoodAndBeverageEvent1Amt
Entertainment Event1	$0	EntertainmentEvent1Amt
Other Direct Expenses Event1	$142,580	OtherDirectExpensesEvent1Amt
Food And Beverage Other Events	$0	FoodAndBeverageOtherEventsAmt
Entertainment Other Events	$0	EntertainmentOtherEventsAmt
Gross Receipts Total	$87,918	GrossReceiptsTotalAmt
Charitable Contributions Tot	$0	CharitableContributionsTotAmt
Gross Revenue Total Events	$87,918	GrossRevenueTotalEventsAmt
Cash Prizes Total Events	$0	CashPrizesTotalEventsAmt
Non Cash Prizes Total Events	$0	NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events	$0	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$0	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$0	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$142,580	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$142,580	DirectExpenseSummaryEventsAmt
Net Income Summary	-$54,662	NetIncomeSummaryAmt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	0	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (24 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
David A Ross
President and CEO	$372,633	$0	$0	$0	$0	$0	$23,321	$0	$29,795	$0	$425,749	$0	$0	$0
Mark McKinlay
Program Director	$259,698	$0	$0	$0	$0	$0	$23,816	$0	$29,638	$0	$313,152	$0	$0	$0
Patrick O'Carroll
Program Sector Head	$272,456	$0	$0	$0	$0	$0	$24,614	$0	$1,489	$0	$298,559	$0	$0	$0
Paul Emerson
Program Director	$228,008	$0	$4,400	$0	$0	$0	$20,580	$0	$40,908	$0	$293,896	$0	$0	$0
David G Addis
Program Director	$241,288	$0	$0	$0	$0	$0	$21,515	$0	$29,560	$0	$292,363	$0	$0	$0
Rubina Imitaz
Program Director	$237,381	$0	$0	$0	$0	$0	$21,399	$0	$31,705	$0	$290,485	$0	$0	$0
William P Nichols
Chief Operating Officer	$259,555	$0	$0	$0	$0	$0	$23,358	$0	$1,159	$0	$284,072	$0	$0	$0
Martha Rogers
Program Director	$257,008	$0	$0	$0	$0	$0	$21,405	$0	$1,091	$0	$279,504	$0	$0	$0
Vivian Singletary
Program Director	$213,388	$0	$0	$0	$0	$0	$17,757	$0	$31,281	$0	$262,426	$0	$0	$0
Yao Sodahlon
Program Director	$221,855	$0	$0	$0	$0	$0	$22,508	$0	$1,259	$0	$245,622	$0	$0	$0
Patrick Lammie
Sr. Public Health Scientist	$218,731	$0	$0	$0	$0	$0	$19,679	$0	$985	$0	$239,395	$0	$0	$0
Heather Brooks
Director of Organizational Effectiveness	$181,826	$0	$0	$0	$0	$0	$16,014	$0	$24,042	$0	$221,882	$0	$0	$0
Daniel Martins
Chief Financial Officer	$137,529	$0	$6,100	$0	$2,409	$0	$13,290	$0	$43,139	$0	$202,467	$0	$0	$0
Ellen Wild
Director of Business Strategy	$165,584	$0	$1,500	$0	$0	$0	$15,006	$0	$1,013	$0	$183,103	$0	$0	$0
Teri Plummer McClure
Board Chair	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Paula Lawton Bevington
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Charles H McTier
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Kent Alexander
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
James Jackson
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Deborah Kilpatrick
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Walter Orenstein
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
James W Curran
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Mary Ann Peters
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Wonya Lucas
Board Member	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	Development Authority of DeKalb County	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	581500666	BondIssuerEIN
CUSIP	000000000	CUSIPNum
Bond Issued	2016-12-15	BondIssuedDt
Issue Price	$7,000,000	IssuePriceAmt
Purpose	Finance the purchase of a building	PurposeDesc
Defeased	0	DefeasedInd
On Behalf Of Issuer	0	OnBehalfOfIssuerInd
Pool Financing	0	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Retired	$1,225,000	RetiredAmt
Bond Defeased	$0	BondDefeasedAmt
Total Proceeds	$7,000,000	TotalProceedsAmt
In Reserve Fund	$0	InReserveFundAmt
Capitalized Interest	$0	CapitalizedInterestAmt
Refunding Escrow	$0	RefundingEscrowAmt
Issuance Costs From Proceeds	$0	IssuanceCostsFromProceedsAmt
Credit Enhancement	$0	CreditEnhancementAmt
Working Capital Expenditures	$0	WorkingCapitalExpendituresAmt
Capital Expenditures	$7,000,000	CapitalExpendituresAmt
Other Spent Proceeds	$0	OtherSpentProceedsAmt
Unspent	$0	UnspentAmt
Substantial Completion	2018	SubstantialCompletionYr
Refunding Tax Exempt Bonds	0	RefundingTaxExemptBondsInd
Refunding Taxable Bonds	0	RefundingTaxableBondsInd
Final Allocation Made	Yes (1)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (1)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	0	OwningBondFinancedPropertyInd
Any Lease Arrangements	0	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	0	MgmtContractBondFincdPropInd
Any Research Agreements	0	AnyResearchAgreementsInd
Private Bus Use By Others	0	PrivateBusUseByOthersPct
Private Bus Concerning UBI	0	PrivateBusConcerningUBIPct
Total Private Business Use	0	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	Yes (1)	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	0	ChangeInUseBondFinancedPropInd
Procs Nonqualified Bond Remdtd	0	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	0	Form8038TFiledInd
Rebate Not Due Yet	0	RebateNotDueYetInd
Exception To Rebate	0	ExceptionToRebateInd
No Rebate Due	0	NoRebateDueInd
Variable Rate Issue	Yes (1)	VariableRateIssueInd
Hedge Identified In Bks And Rec	Yes (1)	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	Truist Bank (formerly Sun Trust Bank)	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Term Of Hedge	16.9	TermOfHedgePct
Superintegrated Hedge	0	SuperintegratedHedgeInd
Hedge Terminated	0	HedgeTerminatedInd
Gross Proceeds Invested In GIC	0	GrossProceedsInvestedInGICInd
Gross Proceeds Invested	0	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	0	WrittenProcToMonitorReqsInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Form 990, Part VI, Section B, Line 11b	Once the Return is prepared by the CFO, it is reviewed by management and thereafter made available to all board members for comments, clarifications and corrections. After the board's review, the Return is finalized and filed with the IRS.
Form 990, Part VI, Section B, Line 12c	Board members, officers, and all employees are required to annually sign a declaration that they have read, and have complied with, the Conflict of Interest Policy. Any suspected or reported violations of the policy are to be referred to the Chief Operating Officer who would follow-up and investigate the matter.
Form 990, Part VI, Section B, Line 15	The Task Force for Global Health, Inc. is an affiliate of Emory University and as such, all its employees are in fact Emory employees. For both the President and Chief Operating Officer, Emory includes these positions in its annual market review of compensated professionals in these categories. In addition, performance is measured against SMART goals. Furthermore, the board reviews performance including a 360 feedback loop finalizing the President's performance.
Form 990, Part VI, Section C, Line 19	Three years of audited financial statements and 990 Tax Returns are posted on the organization's website together with the Conflict of Interest policy and governing documents - Bylaws.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	Global Health Solutions Inc	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	325 Swanton Way	AddressLine1Txt
City	Decatur	CityNm
State Abbreviation	GA	StateAbbreviationCd
ZIP	30030	ZIPCd

Field	Value	IRS element (for citing)
EIN	203674498	EIN
Primary Activities	Oversees donated pharmaceutical products	PrimaryActivitiesTxt
Legal Domicile State	GA	LegalDomicileStateCd
Exempt Code Section	501 (c)(3)	ExemptCodeSectionTxt
Public Charity Status	509(a)(3) Type 1	PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	None	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Controlled Organization	0	ControlledOrganizationInd

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	0	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	0	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	0	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	0	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	0	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (1)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (1)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	0	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (2 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
Global Health Solutions Inc
n	$24,903,202	Net fixed asset of the Task Force as reported in the FY2020 audit report.
Global Health Solutions Inc
o	$0	Payroll cost of staff associated with donated pharmaceuticals.